NUVL · As filed with the SEC

Nuvalent income statement, by fiscal year

The statement as Nuvalent presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS · USD

USDFY2025
Year ended Dec 31, 2025
FY2024
Year ended Dec 31, 2024
FY2023
Year ended Dec 31, 2023
Operating expenses:
Research and development306,970,000217,774,000113,243,000
General and administrative107,337,00062,594,00036,249,000
Total operating expenses414,307,000280,368,000149,492,000
Loss from operations(414,307,000)(280,368,000)(149,492,000)
Other income (expense):
Change in fair value of related party revenue share liability(55,220,000)(17,940,000)0
Interest income and other income (expense), net44,735,00038,316,00023,273,000
Total other income (expense), net(10,485,000)20,376,00023,273,000
Loss before income taxes(424,792,000)(259,992,000)(126,219,000)
Income tax provision585,000764,0000
Net loss(425,377,000)(260,756,000)(126,219,000)
Net loss per share attributable to Class A and Class B common stockholders, basic(5.85)(3.93)(2.17)
Net loss per share attributable to Class A and Class B common stockholders, diluted(5.85)(3.93)(2.17)
Weighted average shares of Class A and Class B common stock outstanding, basic72,686,74966,408,80758,223,339
Weighted average shares of Class A and Class B common stock outstanding, diluted72,686,74966,408,80758,223,339
Comprehensive loss:
Net loss(425,377,000)(260,756,000)(126,219,000)
Other comprehensive income (loss):
Unrealized gains (losses) on marketable securities2,412,000(90,000)525,000
Comprehensive loss(422,965,000)(260,846,000)(125,694,000)

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.